These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 8740797
1. Phase I study of paclitaxel (Taxol) and ifosfamide in previously untreated patients with advanced non-small-cell lung cancer. A study of the National Cancer Institute of Canada Clinical Trials Group. Shepherd FA, Latreille J, Crump M, Stewart D, Tomiak E, Eisenhauer E, Fisher B. Ann Oncol; 1996 Mar; 7(3):311-3. PubMed ID: 8740797 [Abstract] [Full Text] [Related]
2. Phase I dose-escalation trial of paclitaxel and ifosfamide in patients with advanced non-small cell lung cancer. Shepherd FA, Latreille J, Paul K, Eisenhauer E. Semin Oncol; 1996 Dec; 23(6 Suppl 16):84-90. PubMed ID: 9007130 [Abstract] [Full Text] [Related]
3. Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study. Hoffman PC, Masters GA, Drinkard LC, Krauss SA, Samuels BL, Golomb HM, Vokes EE. Ann Oncol; 1996 Mar; 7(3):314-6. PubMed ID: 8740798 [Abstract] [Full Text] [Related]
4. Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer. Hoffman PC, Krauss SA, Drinkard LC, Masters GA, Samuels BL, Bitran JD, Golomb HM, Watson S, Vokes EE. Semin Oncol; 1995 Aug; 22(4 Suppl 9):38-41. PubMed ID: 7544026 [Abstract] [Full Text] [Related]
5. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer. Strauss GM, Lynch TJ, Elias AD, Jacobs C, Kwiatkowski DJ, Shulman LN, Carey RW, Grossbard ML, Jauss S, Sugarbaker DJ. Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029 [Abstract] [Full Text] [Related]
6. A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer. Masters GA, Mauer AM, Hoffman PC, Wyka D, Samuels BL, Krauss SA, Watson S, Golomb H, Vokes EE. Ann Oncol; 1998 Jun; 9(6):677-80. PubMed ID: 9681085 [Abstract] [Full Text] [Related]
7. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer. Masters GA, Hoffman PC, Drinkard LC, Watson S, Samuels BL, Golomb HM, Vokes EE. Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230 [Abstract] [Full Text] [Related]
8. Phase II study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer. Thongprasert S. Lung Cancer; 1998 Mar; 19(3):185-9. PubMed ID: 9631366 [Abstract] [Full Text] [Related]
10. A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B study. Graziano SL, Herndon JE, Richards F, DiFino S, Modeas C, Duggan DB, Green MR. Cancer; 1993 Jul 01; 72(1):62-8. PubMed ID: 8389667 [Abstract] [Full Text] [Related]
13. Paclitaxel and carboplatin: a phase I study in advanced non-small cell lung cancer. Paccagnella A, Favaretto A, Oniga F, Ossana L. Semin Oncol; 1996 Dec 01; 23(6 Suppl 16):76-9. PubMed ID: 9007128 [Abstract] [Full Text] [Related]
17. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network. Langer CJ, Millenson M, O'Dwyer P, Kosierowski R, Alexander R, Litwin S, McAleer CA, Bonjo CA, Ozols R. Semin Oncol; 1996 Dec 01; 23(6 Suppl 16):35-41. PubMed ID: 9007119 [Abstract] [Full Text] [Related]
18. Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancer. Giaccone G, Huizing M, Postmus PE, ten Bokkel Huinink WW, Koolen M, van Zandwijk N, Vermorken JB, Beijnen JH, Dalesio O, Pinedo HM. Semin Oncol; 1995 Aug 01; 22(4 Suppl 9):78-82. PubMed ID: 7544030 [Abstract] [Full Text] [Related]